Advance brain cancer initiatives by joining EBCI’s Board as a Legal Attorney! Send your cover letter and resume to Dellann@EndBrainCancer.org today.
Advance brain cancer initiatives by joining EBCI’s Board as a Legal Attorney! Send your cover letter and resume to Dellann@EndBrainCancer.org today.
Explore the Brain Tumour Patients' Charter of Rights today. Learn your 10 fundamental rights and share feedback to empower patients.
The End Brain Cancer Initiative is seeking brain cancer patients to share video testimonials describing how Belay Diagnostics' liquid biopsy tests helped them.
Learn about the Phase 2 clinical trial of Immune12 for glioblastoma (GBM) patients in Australia, managed by the End Brain Cancer Initiative.
Share your story! The End Brain Cancer Initiative is conducting patient interviews and video testimonials on Belay Diagnostics' CSF liquid biopsy tests.
Join the End Brain Cancer Initiative for GBM Awareness Day to support glioblastoma patients with specialized 1:1 navigation and access to clinical trials.
ROADS Trial Phase 3 results show tile-based radiation significantly improves overall survival & tumor control for newly diagnosed brain metastases.
The End Brain Cancer Initiative wishes you and your family a happy and safe Independence Day.
Discover how Belay Diagnostics' minimally invasive liquid biopsy technique, using cerebrospinal fluid (CSF), guides GBM & rGBM diagnosis and treatment.
We are excited to announce the addition of Dr. Morana Vojnic to the End Brain Cancer Initiative's Medical Advisory Board!
Imaging Biometrics reports Phase 1 results for oral Gallium Maltolate (GaM) in recurrent glioblastoma (GBM), showing high tolerance & extended survival.
Free patient disease education videos from the End Brain Cancer Initiative's 2026 "Know All Your GBM/rGBM Treatment Options" online event are now available!
